U.S. Digital Neuro Biomarkers Market is projected to rise at 25.00% CAGR, while Europe advances at 23.80% as digital health policies, remote monitoring and precision neurology accelerate adoption.
Austin, United States, Aug. 24, 2026 (GLOBE NEWSWIRE) -- The Digital Neuro Biomarkers Market was valued at USD 0.90 Billion in 2025 and is expected to reach USD 8.34 Billion by 2035, growing at a CAGR of 24.97% from 2026 to 2035, according to a new report by SNS Insider.
Digital neuro biomarkers are increasingly being adopted due to the need to monitor the movement, speech, and cognitive functions on a continuous basis. Factors driving market growth include increased prevalence of chronic neurological diseases, technological advancements in the wearables/mobile devices space, and increasing preference for remote monitoring among health care providers, pharmaceuticals and biotechnology firms.
Download the Digital Neuro Biomarkers Market Sample Report: https://www.snsinsider.com/sample-request/5498
Digital Neuro Biomarkers Market Growth Drivers: Neurological Disease Burden, Remote Monitoring and Personalized Medicine
An increase in the incidence of neurological conditions is leading to an increased requirement for solutions that will help in acquiring patient signals outside clinical consultations. In addition, developments in digital healthcare technology, remote patient monitoring, and precision medicine have expanded the role of digital neuro biomarkers in disease surveillance, diagnosis, and evaluation of treatments. Neurological data acquisition through wearables, smartphone applications, and sensor technologies has led to their broader application.
Digital Neuro Biomarkers Market Key Takeaways
- Leading Type: Wearables
- Leading Clinical Practice: Monitoring
- Leading End Use: Healthcare Providers
- Largest Regional Market: North America (~37.70% share)
- Fastest-Growing Regional Market: Europe
Market Segmentation:
By Type: Wearables Lead; Mobile Applications Grow Fastest
Wearable had the highest market share in 2025, led by wearable devices equipped with sensors that help in collecting data related to movements, walking gait, and physiology related to the progression of neurological diseases passively and continuously. Mobile Application is the fastest-growing segment due to the increasing use of mobile applications for conducting cognitive and speech analysis of patients.
By Clinical Practice: Monitoring Leads; Predictive and Prognostic Applications Accelerate
Practice Monitoring had the highest market share in 2025, as a result of the persistent need for monitoring the progress of disease development in patients suffering from neurological disorders, such as Parkinson's disease and multiple sclerosis. Predictive and Prognostic will have the highest growth rate, given the rising trend of early diagnosis and prevention of neurological disorders.
By End Use: Healthcare Providers Lead; Pharma and Biotech Expand Fastest
In 2025, Healthcare Providers captured the highest market share, which comprised hospitals, neurology clinics, and specialized practices that utilized digital biomarkers in the routine process of patient diagnoses. In terms of growth rate, Pharmaceutical and Biotechnology Companies were the fastest-growing end users as the adoption of digital biomarkers continued to increase amid greater R&D spending to test treatment effectiveness for neurological diseases.
Regional Outlook: North America Leads; Europe Is the Fastest-Growing Market
North America was leading all other regions with the largest market share in 2025 by producing around 37.70% of overall revenues across the globe as there was a rising requirement for diagnosing neurological diseases, leading to a huge demand for neurological biomarkers. Favorable regulatory approvals and higher reimbursement for digital technologies were among some other factors that helped in maintaining its market supremacy.
The U.S. Digital Neuro Biomarkers Market size is estimated to be at around USD 0.288 Billion in 2025 and is forecasted to touch around USD 2.68 Billion by 2035, registering a CAGR of around 25.00% during the review period of 2026 to 2035. The market growth is being fueled by close to a million of multiple sclerosis patients along with the rising number of older patients vulnerable to Alzheimer's and Parkinson's diseases.
Europe Digital Neuro Biomarkers Market size is expected to reach about USD 0.25 Billion in 2025 and grow up to USD 2.13 Billion by 2035, registering a CAGR of about 23.80% in the 2026-2035 period, with the revenue share accounting to about 27.78% of global market revenue in 2025. The Europe Digital Neuro Biomarkers Market is experiencing tremendous growth attributed to the rising incidences of neuro disorders and digital health government policies in Europe. In addition, Germany has been contributing to about 27.30% of European revenue due to the availability of various biopharmaceutical companies and research centers in the country.
The Asia-Pacific region had captured a large share of global revenue in 2025, owing to the rapidly aging population, investments in healthcare infrastructure development, and clinical research in the region's largest economies. In 2025, Japan had accounted for about 35.80% of the Asia Pacific's revenue, attributable to the rapidly aging population and high use of healthcare technologies.
Explore the Complete Digital Neuro Biomarkers Market Report: https://www.snsinsider.com/reports/digital-neuro-biomarkers-market-5498
Digital Neuro Biomarkers Market Companies Covered in the Report
- Altoida Inc.
- Koneksa Health
- Biogen Inc.
- F. Hoffmann-La Roche Ltd.
- NeuraMetrix, Inc.
- Merck KGaA
- Linus Health, Inc.
- Neurotrack Technologies, Inc.
- Huma Therapeutics Ltd.
- NeuraLight, Ltd.
- QIAGEN N.V.
- ADx NeuroSciences NV
- Thermo Fisher Scientific Inc.
- Cognito Therapeutics, Inc.
- Click Therapeutics, Inc.
- Akili Interactive Labs, Inc.
- Sonde Health, Inc.
- Winterlight Labs Inc.
- Emerald Innovations, Inc.
- Rune Labs, Inc.
Recent Developments:
- 2025: Koneksa Health continued expanding its digital endpoint platform, targeting pharmaceutical and biotechnology companies seeking validated digital biomarkers for neurological clinical trial applications.
- 2025: Neurotrack Technologies continued developing its cognitive assessment technology, strengthening its position serving healthcare providers and payers seeking early detection tools for cognitive decline.
Exclusive Sections of the Report (The USPs):
- DIGITAL BIOMARKER & TECHNOLOGY PERFORMANCE METRICS – helps you understand adoption trends across wearable, mobile and sensor-based neuro biomarkers and digital neurological assessment platforms globally.
- NEUROLOGICAL DISORDER & DISEASE MONITORING METRICS – helps you evaluate digital biomarker adoption across neurological disorders, patient monitoring applications and precision neurology investment trends globally.
- WEARABLE & SENSOR-BASED MONITORING METRICS – helps you analyze wearable device adoption, continuous neurological monitoring and real-world patient data collection across clinical and research environments globally.
- CLINICAL TRIAL & DRUG DEVELOPMENT METRICS – helps you uncover growth in digital endpoint adoption, decentralized neurological trials and biomarker-driven drug development across pharmaceutical and biotechnology organizations globally.
- AI & DIGITAL NEUROLOGY PLATFORM METRICS – helps you identify growth opportunities in AI-enabled neurological assessment, predictive analytics and remote patient monitoring technologies globally.
- COMPETITIVE LANDSCAPE & DIGITAL NEURO BIOMARKER EXPANSION METRICS – helps you gauge the competitive strength of key market players based on technology portfolio breadth, clinical capabilities and geographic commercial footprint globally.
Buy the Digital Neuro Biomarkers Market Report with Competitive Analysis and 2035 Forecast: https://www.snsinsider.com/checkout/5498
Digital Neuro Biomarkers Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 0.90 Billion |
| Market Size by 2035 | USD 8.34 Billion |
| CAGR | CAGR of 24.97% From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Key Segments | • By Type (Wearables, Mobile Applications, Sensors) • By Clinical Practice (Monitoring, Diagnostic, Predictive and Prognostic) • By End Use (Healthcare Providers, Pharmaceutical and Biotechnology Companies) |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Related Market Reports
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Rohan Jadhav - Principal Consultant Phone: +1-315-961-9094 (US) Email: info@snsinsider.com
Comments (0)
Login to join the conversation
Login / RegisterNo comments yet. Be the first to comment!